These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 24746214)
1. p40 exhibits better specificity than p63 in distinguishing primary skin adnexal carcinomas from cutaneous metastases. Lee JJ; Mochel MC; Piris A; Boussahmain C; Mahalingam M; Hoang MP Hum Pathol; 2014 May; 45(5):1078-83. PubMed ID: 24746214 [TBL] [Abstract][Full Text] [Related]
2. The diagnostic utility of immunohistochemistry in distinguishing primary skin adnexal carcinomas from metastatic adenocarcinoma to skin: an immunohistochemical reappraisal using cytokeratin 15, nestin, p63, D2-40, and calretinin. Mahalingam M; Nguyen LP; Richards JE; Muzikansky A; Hoang MP Mod Pathol; 2010 May; 23(5):713-9. PubMed ID: 20190734 [TBL] [Abstract][Full Text] [Related]
3. Value of p63 and podoplanin (D2-40) immunoreactivity in the distinction between primary cutaneous tumors and adenocarcinomas metastatic to the skin: a clinicopathologic and immunohistochemical study of 79 cases. Plaza JA; Ortega PF; Stockman DL; Suster S J Cutan Pathol; 2010 Apr; 37(4):403-10. PubMed ID: 20377670 [TBL] [Abstract][Full Text] [Related]
4. Use of p63 expression in distinguishing primary and metastatic cutaneous adnexal neoplasms from metastatic adenocarcinoma to skin. Ivan D; Nash JW; Prieto VG; Calonje E; Lyle S; Diwan AH; Lazar AJ J Cutan Pathol; 2007 Jun; 34(6):474-80. PubMed ID: 17518775 [TBL] [Abstract][Full Text] [Related]
6. Podoplanin is a highly sensitive and specific marker to distinguish primary skin adnexal carcinomas from adenocarcinomas metastatic to skin. Liang H; Wu H; Giorgadze TA; Sariya D; Bellucci KS; Veerappan R; Liegl B; Acs G; Elenitsas R; Shukla S; Youngberg GA; Coogan PS; Pasha T; Zhang PJ; Xu X Am J Surg Pathol; 2007 Feb; 31(2):304-10. PubMed ID: 17255777 [TBL] [Abstract][Full Text] [Related]
7. Adenosquamous carcinoma: a report of nine cases with p63 and cytokeratin 5/6 staining. Ko CJ; Leffell DJ; McNiff JM J Cutan Pathol; 2009 Apr; 36(4):448-52. PubMed ID: 19278431 [TBL] [Abstract][Full Text] [Related]
8. Expression of the p40 isoform of p63 has high specificity for cutaneous sarcomatoid squamous cell carcinoma. Ha Lan TT; Chen SJ; Arps DP; Fullen DR; Patel RM; Siddiqui J; Carskadon S; Palanisamy N; Harms PW J Cutan Pathol; 2014 Nov; 41(11):831-8. PubMed ID: 25263756 [TBL] [Abstract][Full Text] [Related]
9. Utilization of p40 (ΔNp63) with p63 and cytokeratin 5/6 immunohistochemistry in non-small cell lung carcinoma fine-needle aspiration biopsy. Collins BT; Wang JF; Bernadt CT Acta Cytol; 2013; 57(6):619-24. PubMed ID: 24107322 [TBL] [Abstract][Full Text] [Related]
10. Is GATA3 expression maintained in regional metastases?: a study of paired primary and metastatic urothelial carcinomas. Zhao L; Antic T; Witten D; Paner GP; Taxy JB; Husain A; Gwin K; Mirza MK; Lingen MW; Tretiakova MS Am J Surg Pathol; 2013 Dec; 37(12):1876-81. PubMed ID: 24121175 [TBL] [Abstract][Full Text] [Related]
11. Usefulness of GATA3 and p40 immunostains in the diagnosis of metastatic urothelial carcinoma in cytology specimens. Brandler TC; Aziz MS; Rosen LM; Bhuiya TA; Yaskiv O Cancer Cytopathol; 2014 Jun; 122(6):468-73. PubMed ID: 24711443 [TBL] [Abstract][Full Text] [Related]
12. p40 is a more specific marker than p63 for cutaneous poorly differentiated squamous cell carcinoma. Alomari AK; Glusac EJ; McNiff JM J Cutan Pathol; 2014 Nov; 41(11):839-45. PubMed ID: 25263848 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical distinction of primary sweat gland carcinoma and metastatic breast carcinoma: can it always be accomplished reliably? Mentrikoski MJ; Wick MR Am J Clin Pathol; 2015 Mar; 143(3):430-6. PubMed ID: 25696802 [TBL] [Abstract][Full Text] [Related]
14. PAX8 discriminates ovarian metastases from adnexal tumors and other cutaneous metastases. Fujiwara M; Taube J; Sharma M; McCalmont TH; Kim J J Cutan Pathol; 2010 Sep; 37(9):938-43. PubMed ID: 20492080 [TBL] [Abstract][Full Text] [Related]
15. GATA3 and MYB Expression in Cutaneous Adnexal Neoplasms. Pardal J; Sundram U; Selim MA; Hoang MP Am J Dermatopathol; 2017 Apr; 39(4):279-286. PubMed ID: 28323779 [TBL] [Abstract][Full Text] [Related]
16. The utility of p63, p40, and GATA-binding protein 3 immunohistochemistry in diagnosing micropapillary urothelial carcinoma. Lin X; Zhu B; Villa C; Zhong M; Kundu S; Rohan SM; Yang XJ Hum Pathol; 2014 Sep; 45(9):1824-9. PubMed ID: 24993315 [TBL] [Abstract][Full Text] [Related]
17. Various Antibody Clones of Napsin A, Thyroid Transcription Factor 1, and p40 and Comparisons With Cytokeratin 5 and p63 in Histopathologic Diagnostics of Non-Small Cell Lung Carcinoma. Tran L; Mattsson JS; Nodin B; Jönsson P; Planck M; Jirström K; Botling J; Micke P; Brunnström H Appl Immunohistochem Mol Morphol; 2016 Oct; 24(9):648-659. PubMed ID: 26447895 [TBL] [Abstract][Full Text] [Related]
18. Well-differentiated neuroendocrine tumors in skin: Terminology and diagnostic utility of cytokeratin 5/6 and p63. Panse G; Cowper SE; Leffell DJ; Pulitzer M; Ko CJ J Cutan Pathol; 2017 Jun; 44(6):557-562. PubMed ID: 28417484 [TBL] [Abstract][Full Text] [Related]
19. Usefulness of monoclonal antibody HIK1083 specific for gastric O-glycan in differentiating cutaneous metastasis of gastric cancer from primary sweat gland carcinoma. Iijima M; Nakayama J; Nishizawa T; Ishida A; Ishii K; Ota H; Katsuyama T; Saida T Am J Dermatopathol; 2007 Oct; 29(5):452-6. PubMed ID: 17890913 [TBL] [Abstract][Full Text] [Related]
20. Expression of p63 in cutaneous metastases. Kanitakis J; Chouvet B Am J Clin Pathol; 2007 Nov; 128(5):753-8. PubMed ID: 17951196 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]